• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Scientific Publications by FDA Staff

  • Print
  • Share
  • E-mail
-

Search Publications



Fields



Centers











Starting Date


Ending Date


Order by

Entry Details

FEBS Open Bio 2012 May 24;2:113-8

Effects of carbon monoxide (CO) delivery by a CO donor or hemoglobin on vascular hypoxia inducible factor 1a and mitochondrial respiration.

Reiter CE, Alayash AI

Abstract

We examined carbon monoxide (CO) delivery by carbon monoxide-releasing molecule 2 (CORM-2) or hemoglobin (Hb) on cellular oxygen sensing and mitochondrial respiration in bovine aortic endothelial cells (BAECs). CORM-2 reduced hypoxia-inducible factor-1a (HIF-1a) and endothelin-1 (ET-1) expression in normoxic and hypoxic cells, but while Hb alone significantly reduced HIF-1a stabilization in hypoxic cells, CO delivered by Hb (Hb-CO) had no effect on HIF-1a stabilization. CO dose-dependently increased basal oxygen consumption and reduced overall mitochondrial respiratory capacity. Hb-CO increased basal oxygen consumption but did not alter respiratory capacity. Together, CO reduced ET-1, and, at low doses, had no effect on endothelial mitochondria oxygen consumption. CO ligation to Hb may be developed further as non-vasoactive oxygen therapeutic without compromising mitochondrial function.


Category: Journal Article
PubMed ID: #23650589 DOI: 10.1016/j.fob.2012.05.003
PubMed Central ID: #PMC3642129
Includes FDA Authors from Scientific Area(s): Biologics
Entry Created: 2012-03-31 Entry Last Modified: 2013-05-14
Feedback
-
-